Scienture Holdings, Inc. (SCNX) is a biotechnology company dedicated to revolutionizing the treatment of neurological disorders through its innovative drug development pipeline and experienced research team. With a strong commitment to addressing critical unmet medical needs, the company is positioned to improve patient outcomes while adeptly managing the complexities of regulatory pathways. Scienture's focus on scientific rigor, coupled with strategic partnerships, enhances its growth potential and solidifies its role as a significant player in the global healthcare market. As demand for…